2005
Relationship between provider type and the attainment of treatment goals in primary care.
Federman DG, Krishnamurthy R, Kancir S, Goulet J, Justice A. Relationship between provider type and the attainment of treatment goals in primary care. The American Journal Of Managed Care 2005, 11: 561-6. PMID: 16159046.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseProvider typeArtery diseaseBlood pressureDiabetes mellitusTreatment goalsRecent low-density lipoprotein cholesterol levelsLow-density lipoprotein cholesterol levelsAdditional patient characteristicsBlood pressure goalsGoal blood pressureLipoprotein cholesterol levelsClinical Modification codesTreatment of dyslipidemiaTreatment of hypertensionElectronic medical recordsHealth care systemInternal medicine residentsPatient agePatient characteristicsHemoglobin levelsNinth RevisionPrimary careCholesterol levelsMedical records
2001
Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. PMID: 11702815, DOI: 10.1097/00007611-200110000-00016.Peer-Reviewed Original ResearchConceptsStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesCliniciansFatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. DOI: 10.1097/00007611-200194100-00017.Peer-Reviewed Original ResearchStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesClinicians
1998
Epidemiology of peripheral vascular disease: a predictor of systemic vascular disease.
Federman D, Trent J, Froelich C, Demirovic J, Kirsner R. Epidemiology of peripheral vascular disease: a predictor of systemic vascular disease. Wound Management & Prevention 1998, 44: 58-62, 64, 66 passim. PMID: 9697547.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseSystemic vascular diseaseSymptomatic peripheral vascular diseaseBody mass indexVascular diseaseRisk factorsPrevalence of PVDLower body mass indexCoronary artery diseaseCoronary heart diseasePhysical examination findingsImportant risk factorArtery diseaseHDL cholesterolExamination findingsLow ABIMass indexCerebrovascular diseaseCigarette smokingHeart diseasePhysical activityAdult populationOrgan systemsDiseasePatients